RecruitingNCT06066775

Endocrine Glucose & Lipids Metabolism and Brain Aging: a Longitudinal Study

A Prospective Cohort Study on the Associations of Endocrine Glucose & Lipids With Brain Aging-related Conditions in Chinese Men and Women


Sponsor

Shandong Provincial Hospital

Enrollment

10,000 participants

Start Date

Jul 4, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

With aging, brain aging leads to a general decline in cognitive ability, and the prevalence of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) increases. The prevalence of abnormal glucose and lipid metabolism also increased with age. The imbalance of glucose and lipid metabolism is closely related to brain aging related conditions and diseases, and the relationship between glucose and lipid metabolism and brain aging has not been fully elucidated. Phase 1: Baseline investigation (community-based survey) Aims: To investigate whether glucose and lipids are the risk factors for brain aging-related conditions, such as mild cognitive impairment. Subjects and Methods: A community-based survey will be carried out in 10000 natural population aged \>=50 years selected from 10-12 communities stratified according to geographic regions (Ciyao, Huafeng, Dongzhuang, Heshan, Geshi, Jiangji, Gangcheng, Fushan, Dongshu, Sidian, Baxianqiao, and Xiangyin, etc) in Ningyang County, Taian City, Shandong Province. A comprehensive examination including questionnaire (including the MMSE and ADL evaluation for the participants), anthropometric measurements, biochemical analysis will be performed in each study participant. In particular, the investigators randomly selected 1000-2000 participants performing MRI of the brain to evaluate the brain aging related conditions. Phase 2: Cohort follow-up Aims : To examine glucose and lipids metabolism levels and their changes that modify the risk of brain aging-related conditions. Subjects and Methods: To recruit and follow all 10000 participants for at least 3-5 years. In particular, all 1000-2000 participants with the baseline MRI examination will perform the MRI examination again for the follow-up.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This longitudinal study (meaning it follows people over time) examines how hormones, blood sugar and fat metabolism, and brain aging are connected — specifically looking at factors that may contribute to cognitive decline and dementia as people get older. **You may be eligible if...** - You are 50 years of age or older - You are male or female - You do not have a significant history of neurological, psychiatric, or serious systemic disease - You can provide written informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have a history of addiction, depression, epilepsy, head trauma, or other conditions known to affect brain function - You have any major medical condition the study team feels would interfere with participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservation study without intervention

Observation study without intervention


Locations(1)

Shandong Provincial Hospital Affiliated to Shandong First Medical University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06066775